Fondazione Del Piemonte Per L'oncologia
Clinical trials sponsored by Fondazione Del Piemonte Per L'oncologia, explained in plain language.
-
Can surgery boost control of spread prostate cancer?
Disease control OngoingThis study tests whether robot-assisted removal of the prostate, along with lymph node dissection, can help control cancer in men with oligometastatic hormone-sensitive prostate cancer—cancer that has spread to a few spots in the spine or pelvis. Participants have been on hormone…
Phase: NA • Sponsor: Fondazione del Piemonte per l'Oncologia • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New prostate cancer screening method aims to cut unnecessary biopsies
Diagnosis ENROLLING_BY_INVITATIONThis pilot study is testing a new screening pathway for prostate cancer in men aged 55-65. Instead of relying only on PSA blood tests, participants with elevated PSA will also get a risk assessment and an MRI. The goal is to better distinguish between slow-growing cancers that do…
Phase: NA • Sponsor: Fondazione del Piemonte per l'Oncologia • Aim: Diagnosis
Last updated Jun 27, 2026 09:11 UTC
-
Tumor DNA study aims to unlock secrets of drug resistance
Knowledge-focused OngoingThis study collects tumor tissue, blood, and saliva from 2500 people with various solid cancers to analyze their genetic makeup. The goal is to understand why some tumors become resistant to targeted therapies. Samples may also be grown in special mice to study how genetics affec…
Sponsor: Fondazione del Piemonte per l'Oncologia • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC